WASHINGTON — Patients who better adhered to topical glaucoma medications over time experienced a slower rate of visual field decline compared with patients with poor adherence to their medications, according to a speaker here.
“Improving patient adherence to topical glaucoma medications may delay visual field progression. Strategies to improve adherence include sustained-release products that minimize the need for daily patient compliance and allow the patients to preserve vision for longer,” Donald S. Fong, MD, said at the American Glaucoma Society annual meeting.
In the
Uncategorized